Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Acute myeloid leukemia 💬
1件: KIT 💬 Barzolvolimab 💬 Barzolvolimab 1件: 98 💬
2 Acute myeloid leukemia 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
3 Adipocytokine signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
4 Adipocytokine signaling pathway 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
5 Adrenergic signaling in cardiomyocytes 💬
1件: AGTR1 💬 Losartan potassium 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
6 Adrenergic signaling in cardiomyocytes 💬
1件: AGTR1 💬 Losartan 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
7 African trypanosomiasis 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
8 AGE-RAGE signaling pathway in diabetic complications 💬
1件: AGTR1 💬 Losartan potassium 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
9 AGE-RAGE signaling pathway in diabetic complications 💬
1件: AGTR1 💬 Losartan 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
10 AGE-RAGE signaling pathway in diabetic complications 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
11 Alcoholic liver disease 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
12 Aldosterone synthesis and secretion 💬
1件: AGTR1 💬 Losartan potassium 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
13 Aldosterone synthesis and secretion 💬
1件: AGTR1 💬 Losartan 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
14 Allograft rejection 💬
1件: IL5 💬 Mepolizumab 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
15 Allograft rejection 💬
1件: IL5 💬 Reslizumab 💬 Reslizumab 2件: 44, 98 💬
16 Allograft rejection 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
17 Alzheimer disease 💬
3件: CHRM1, CHRM3, CHRM5 💬 Bethanechol chloride 💬 Bethanechol 1件: 98 💬
18 Alzheimer disease 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
19 Alzheimer disease 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
20 Amoebiasis 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
21 AMPK signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
22 Amyotrophic lateral sclerosis 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
23 Amyotrophic lateral sclerosis 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
24 Antigen processing and presentation 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
25 Apelin signaling pathway 💬
1件: AGTR1 💬 Losartan potassium 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
26 Apelin signaling pathway 💬
1件: AGTR1 💬 Losartan 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
27 Apelin signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
28 Apoptosis 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
29 Asthma 💬
1件: FCER1A 💬 Omalizumab 💬 Omalizumab 7件: 46, 53, 65, 98, 162, 226, 299 💬
30 Asthma 💬
1件: IL13 💬 Cendakimab 💬 Cendakimab 1件: 98 💬
31 Asthma 💬
1件: IL5 💬 Mepolizumab 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
32 Asthma 💬
1件: IL5 💬 Reslizumab 💬 Reslizumab 2件: 44, 98 💬
33 Asthma 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
34 Autoimmune thyroid disease 💬
1件: IL5 💬 Mepolizumab 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
35 Autoimmune thyroid disease 💬
1件: IL5 💬 Reslizumab 💬 Reslizumab 2件: 44, 98 💬
36 Autophagy - animal 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
37 Autophagy - other 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
38 Breast cancer 💬
1件: KIT 💬 Barzolvolimab 💬 Barzolvolimab 1件: 98 💬
39 Breast cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
40 C-type lectin receptor signaling pathway 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
41 Calcium signaling pathway 💬
1件: AGTR1 💬 Losartan potassium 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
42 Calcium signaling pathway 💬
1件: AGTR1 💬 Losartan 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
43 Calcium signaling pathway 💬
4件: CHRM1, CHRM2, CHRM3, CHRM5 💬 Bethanechol chloride 💬 Bethanechol 1件: 98 💬
44 Calcium signaling pathway 💬
1件: CYSLTR1 💬 Montelukast sodium 💬 Montelukast 9件:  6 , 13, 19, 46, 61, 63, 85, 98, 228 💬
45 Calcium signaling pathway 💬
1件: CYSLTR1 💬 Montelukast 💬 Montelukast 9件:  6 , 13, 19, 46, 61, 63, 85, 98, 228 💬
46 Calcium signaling pathway 💬
1件: HRH1 💬 Loratadine 💬 Loratadine 5件: 13, 19, 46, 89, 98 💬
47 Calcium signaling pathway 💬
1件: HRH2 💬 Famotidine 💬 Famotidine 7件:  6 , 46, 61, 86, 98, 145, 300 💬
48 cAMP signaling pathway 💬
2件: CHRM1, CHRM2 💬 Bethanechol chloride 💬 Bethanechol 1件: 98 💬
49 Cellular senescence 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
50 Central carbon metabolism in cancer 💬
1件: KIT 💬 Barzolvolimab 💬 Barzolvolimab 1件: 98 💬
51 Central carbon metabolism in cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
52 cGMP-PKG signaling pathway 💬
1件: AGTR1 💬 Losartan potassium 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
53 cGMP-PKG signaling pathway 💬
1件: AGTR1 💬 Losartan 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
54 Chagas disease 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
55 Chemical carcinogenesis - receptor activation 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
56 Chemical carcinogenesis - receptor activation 💬
1件: VDR 💬 Cholecalciferol 💬 Cholecalciferol 23件:  6 , 11, 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 65, 84, 85, 96, 97, 98, 162, 228, 271, 298, 299 💬
57 Choline metabolism in cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
58 Cholinergic synapse 💬
5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 Bethanechol chloride 💬 Bethanechol 1件: 98 💬
59 Collecting duct acid secretion 💬
2件: ATP4A, ATP4B 💬 Dexlansoprazole 💬 Dexlansoprazole 1件: 98 💬
60 Collecting duct acid secretion 💬
2件: ATP4A, ATP4B 💬 Dexlansoprazole sesquihydrate 💬 Dexlansoprazole 1件: 98 💬
61 Collecting duct acid secretion 💬
2件: ATP4A, ATP4B 💬 Esomeprazole magnesium 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
62 Collecting duct acid secretion 💬
2件: ATP4A, ATP4B 💬 Esomeprazole sodium 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
63 Collecting duct acid secretion 💬
2件: ATP4A, ATP4B 💬 Esomeprazole 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
64 Collecting duct acid secretion 💬
2件: ATP4A, ATP4B 💬 Esomeprazole strontium 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
65 Collecting duct acid secretion 💬
2件: ATP4A, ATP4B 💬 Esomeprazole magnesium dihydrate 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
66 Collecting duct acid secretion 💬
2件: ATP4A, ATP4B 💬 Omeprazole 💬 Omeprazole 16件:  6 , 13, 21, 46, 51, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
67 Collecting duct acid secretion 💬
2件: ATP4A, ATP4B 💬 Omeprazole sodium 💬 Omeprazole 16件:  6 , 13, 21, 46, 51, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
68 Collecting duct acid secretion 💬
2件: ATP4A, ATP4B 💬 Omeprazole magnesium 💬 Omeprazole 16件:  6 , 13, 21, 46, 51, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
69 Collecting duct acid secretion 💬
2件: ATP4A, ATP4B 💬 Vonoprazan 💬 Vonoprazan 3件: 63, 97, 98 💬
70 Colorectal cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
71 Coronavirus disease - COVID-19 💬
1件: AGTR1 💬 Losartan potassium 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
72 Coronavirus disease - COVID-19 💬
1件: AGTR1 💬 Losartan 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
73 Coronavirus disease - COVID-19 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
74 Cortisol synthesis and secretion 💬
1件: AGTR1 💬 Losartan potassium 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
75 Cortisol synthesis and secretion 💬
1件: AGTR1 💬 Losartan 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
76 Cushing syndrome 💬
1件: AGTR1 💬 Losartan potassium 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
77 Cushing syndrome 💬
1件: AGTR1 💬 Losartan 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
78 Cytokine-cytokine receptor interaction 💬
1件: IL13 💬 Cendakimab 💬 Cendakimab 1件: 98 💬
79 Cytokine-cytokine receptor interaction 💬
1件: IL4R 💬 Dupilumab 💬 Dupilumab 5件: 51, 97, 98, 160, 162 💬
80 Cytokine-cytokine receptor interaction 💬
1件: IL5 💬 Mepolizumab 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
81 Cytokine-cytokine receptor interaction 💬
1件: IL5 💬 Reslizumab 💬 Reslizumab 2件: 44, 98 💬
82 Cytokine-cytokine receptor interaction 💬
1件: IL5RA 💬 Benralizumab 💬 Benralizumab 5件: 44, 45, 98, 162, 299 💬
83 Cytokine-cytokine receptor interaction 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
84 Cytokine-cytokine receptor interaction 💬
1件: TSLP 💬 Tezepelumab 💬 Tezepelumab 3件: 44, 45, 98 💬
85 Cytokine-cytokine receptor interaction 💬
1件: TSLPR 💬 Solrikitug 💬 Solrikitug 1件: 98 💬
86 Diabetic cardiomyopathy 💬
1件: AGTR1 💬 Losartan potassium 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
87 Diabetic cardiomyopathy 💬
1件: AGTR1 💬 Losartan 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
88 Diabetic cardiomyopathy 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
89 Dilated cardiomyopathy 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
90 Efferocytosis 💬
1件: S1PR1 💬 Etrasimod 💬 Etrasimod 3件: 96, 97, 98 💬
91 Efferocytosis 💬
1件: S1PR1 💬 Etrasimod arginine 💬 Etrasimod 3件: 96, 97, 98 💬
92 Endocrine and other factor-regulated calcium reabsorption 💬
1件: VDR 💬 Cholecalciferol 💬 Cholecalciferol 23件:  6 , 11, 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 65, 84, 85, 96, 97, 98, 162, 228, 271, 298, 299 💬
93 Epstein-Barr virus infection 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
94 ErbB signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
95 Fc epsilon RI signaling pathway 💬
1件: FCER1A 💬 Omalizumab 💬 Omalizumab 7件: 46, 53, 65, 98, 162, 226, 299 💬
96 Fc epsilon RI signaling pathway 💬
1件: IL13 💬 Cendakimab 💬 Cendakimab 1件: 98 💬
97 Fc epsilon RI signaling pathway 💬
1件: IL5 💬 Mepolizumab 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
98 Fc epsilon RI signaling pathway 💬
1件: IL5 💬 Reslizumab 💬 Reslizumab 2件: 44, 98 💬
99 Fc epsilon RI signaling pathway 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
100 Fluid shear stress and atherosclerosis 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
101 FoxO signaling pathway 💬
2件: S1PR1, S1PR4 💬 Etrasimod 💬 Etrasimod 3件: 96, 97, 98 💬
102 FoxO signaling pathway 💬
2件: S1PR1, S1PR4 💬 Etrasimod arginine 💬 Etrasimod 3件: 96, 97, 98 💬
103 GABAergic synapse 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
104 Gastric acid secretion 💬
2件: ATP4A, ATP4B 💬 Dexlansoprazole 💬 Dexlansoprazole 1件: 98 💬
105 Gastric acid secretion 💬
2件: ATP4A, ATP4B 💬 Dexlansoprazole sesquihydrate 💬 Dexlansoprazole 1件: 98 💬
106 Gastric acid secretion 💬
2件: ATP4A, ATP4B 💬 Esomeprazole magnesium 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
107 Gastric acid secretion 💬
2件: ATP4A, ATP4B 💬 Esomeprazole sodium 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
108 Gastric acid secretion 💬
2件: ATP4A, ATP4B 💬 Esomeprazole 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
109 Gastric acid secretion 💬
2件: ATP4A, ATP4B 💬 Esomeprazole strontium 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
110 Gastric acid secretion 💬
2件: ATP4A, ATP4B 💬 Esomeprazole magnesium dihydrate 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
111 Gastric acid secretion 💬
2件: ATP4A, ATP4B 💬 Omeprazole 💬 Omeprazole 16件:  6 , 13, 21, 46, 51, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
112 Gastric acid secretion 💬
2件: ATP4A, ATP4B 💬 Omeprazole sodium 💬 Omeprazole 16件:  6 , 13, 21, 46, 51, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
113 Gastric acid secretion 💬
2件: ATP4A, ATP4B 💬 Omeprazole magnesium 💬 Omeprazole 16件:  6 , 13, 21, 46, 51, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
114 Gastric acid secretion 💬
2件: ATP4A, ATP4B 💬 Vonoprazan 💬 Vonoprazan 3件: 63, 97, 98 💬
115 Gastric acid secretion 💬
1件: CHRM3 💬 Bethanechol chloride 💬 Bethanechol 1件: 98 💬
116 Gastric acid secretion 💬
1件: HRH2 💬 Famotidine 💬 Famotidine 7件:  6 , 46, 61, 86, 98, 145, 300 💬
117 Gastric cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
118 Glioma 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
119 Graft-versus-host disease 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
120 Growth hormone synthesis, secretion and action 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
121 Hematopoietic cell lineage 💬
1件: IL4R 💬 Dupilumab 💬 Dupilumab 5件: 51, 97, 98, 160, 162 💬
122 Hematopoietic cell lineage 💬
1件: IL5 💬 Mepolizumab 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
123 Hematopoietic cell lineage 💬
1件: IL5 💬 Reslizumab 💬 Reslizumab 2件: 44, 98 💬
124 Hematopoietic cell lineage 💬
1件: IL5RA 💬 Benralizumab 💬 Benralizumab 5件: 44, 45, 98, 162, 299 💬
125 Hematopoietic cell lineage 💬
1件: KIT 💬 Barzolvolimab 💬 Barzolvolimab 1件: 98 💬
126 Hematopoietic cell lineage 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
127 Hepatitis B 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
128 Hepatitis C 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
129 Hepatocellular carcinoma 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
130 Herpes simplex virus 1 infection 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
131 Herpes simplex virus 1 infection 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
132 HIF-1 signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
133 Hormone signaling 💬
1件: AGTR1 💬 Losartan potassium 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
134 Hormone signaling 💬
1件: AGTR1 💬 Losartan 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
135 Human cytomegalovirus infection 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
136 Human cytomegalovirus infection 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
137 Human immunodeficiency virus 1 infection 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
138 Human immunodeficiency virus 1 infection 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
139 Human papillomavirus infection 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
140 Human papillomavirus infection 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
141 Human T-cell leukemia virus 1 infection 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
142 Huntington disease 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
143 Hypertrophic cardiomyopathy 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
144 IL-17 signaling pathway 💬
1件: IL13 💬 Cendakimab 💬 Cendakimab 1件: 98 💬
145 IL-17 signaling pathway 💬
1件: IL5 💬 Mepolizumab 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
146 IL-17 signaling pathway 💬
1件: IL5 💬 Reslizumab 💬 Reslizumab 2件: 44, 98 💬
147 IL-17 signaling pathway 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
148 Inflammatory bowel disease 💬
1件: IL13 💬 Cendakimab 💬 Cendakimab 1件: 98 💬
149 Inflammatory bowel disease 💬
1件: IL4R 💬 Dupilumab 💬 Dupilumab 5件: 51, 97, 98, 160, 162 💬
150 Inflammatory bowel disease 💬
1件: IL5 💬 Mepolizumab 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
151 Inflammatory bowel disease 💬
1件: IL5 💬 Reslizumab 💬 Reslizumab 2件: 44, 98 💬
152 Inflammatory bowel disease 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
153 Inflammatory mediator regulation of TRP channels 💬
1件: HRH1 💬 Loratadine 💬 Loratadine 5件: 13, 19, 46, 89, 98 💬
154 Influenza A 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
155 Insulin resistance 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
156 Insulin resistance 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
157 Insulin secretion 💬
1件: CHRM3 💬 Bethanechol chloride 💬 Bethanechol 1件: 98 💬
158 Insulin signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
159 Intestinal immune network for IgA production 💬
1件: IL5 💬 Mepolizumab 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
160 Intestinal immune network for IgA production 💬
1件: IL5 💬 Reslizumab 💬 Reslizumab 2件: 44, 98 💬
161 JAK-STAT signaling pathway 💬
1件: IL13 💬 Cendakimab 💬 Cendakimab 1件: 98 💬
162 JAK-STAT signaling pathway 💬
1件: IL4R 💬 Dupilumab 💬 Dupilumab 5件: 51, 97, 98, 160, 162 💬
163 JAK-STAT signaling pathway 💬
1件: IL5 💬 Mepolizumab 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
164 JAK-STAT signaling pathway 💬
1件: IL5 💬 Reslizumab 💬 Reslizumab 2件: 44, 98 💬
165 JAK-STAT signaling pathway 💬
1件: IL5RA 💬 Benralizumab 💬 Benralizumab 5件: 44, 45, 98, 162, 299 💬
166 JAK-STAT signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
167 JAK-STAT signaling pathway 💬
1件: TSLP 💬 Tezepelumab 💬 Tezepelumab 3件: 44, 45, 98 💬
168 JAK-STAT signaling pathway 💬
1件: TSLPR 💬 Solrikitug 💬 Solrikitug 1件: 98 💬
169 Kaposi sarcoma-associated herpesvirus infection 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
170 Legionellosis 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
171 Leishmaniasis 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
172 Lipid and atherosclerosis 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
173 Longevity regulating pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
174 Longevity regulating pathway - multiple species 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
175 Malaria 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
176 MAPK signaling pathway 💬
1件: KIT 💬 Barzolvolimab 💬 Barzolvolimab 1件: 98 💬
177 MAPK signaling pathway 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
178 Melanogenesis 💬
1件: KIT 💬 Barzolvolimab 💬 Barzolvolimab 1件: 98 💬
179 MicroRNAs in cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
180 Mineral absorption 💬
1件: VDR 💬 Cholecalciferol 💬 Cholecalciferol 23件:  6 , 11, 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 65, 84, 85, 96, 97, 98, 162, 228, 271, 298, 299 💬
181 Morphine addiction 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
182 mTOR signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
183 mTOR signaling pathway 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
184 Natural killer cell mediated cytotoxicity 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
185 Necroptosis 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
186 Neuroactive ligand signaling 💬
5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 Bethanechol chloride 💬 Bethanechol 1件: 98 💬
187 Neuroactive ligand signaling 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
188 Neuroactive ligand signaling 💬
1件: HRH1 💬 Loratadine 💬 Loratadine 5件: 13, 19, 46, 89, 98 💬
189 Neuroactive ligand signaling 💬
1件: HRH2 💬 Famotidine 💬 Famotidine 7件:  6 , 46, 61, 86, 98, 145, 300 💬
190 Neuroactive ligand signaling 💬
5件: HTR3, HTR3, HTR3, HTR3, HTR3 💬 Ondansetron 💬 Ondansetron 5件:  6 , 97, 98, 107, 231 💬
191 Neuroactive ligand signaling 💬
5件: HTR3, HTR3, HTR3, HTR3, HTR3 💬 Ondansetron hydrochloride hydrate 💬 Ondansetron 5件:  6 , 97, 98, 107, 231 💬
192 Neuroactive ligand signaling 💬
1件: SLC6A4 💬 Citalopram hydrobromide 💬 Citalopram 5件:  6 , 13, 46, 98, 127 💬
193 Neuroactive ligand signaling 💬
1件: SLC6A4 💬 Citalopram 💬 Citalopram 5件:  6 , 13, 46, 98, 127 💬
194 Neuroactive ligand-receptor interaction 💬
1件: AGTR1 💬 Losartan potassium 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
195 Neuroactive ligand-receptor interaction 💬
1件: AGTR1 💬 Losartan 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
196 Neuroactive ligand-receptor interaction 💬
5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 Bethanechol chloride 💬 Bethanechol 1件: 98 💬
197 Neuroactive ligand-receptor interaction 💬
1件: CYSLTR1 💬 Montelukast sodium 💬 Montelukast 9件:  6 , 13, 19, 46, 61, 63, 85, 98, 228 💬
198 Neuroactive ligand-receptor interaction 💬
1件: CYSLTR1 💬 Montelukast 💬 Montelukast 9件:  6 , 13, 19, 46, 61, 63, 85, 98, 228 💬
199 Neuroactive ligand-receptor interaction 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
200 Neuroactive ligand-receptor interaction 💬
1件: HRH1 💬 Loratadine 💬 Loratadine 5件: 13, 19, 46, 89, 98 💬
201 Neuroactive ligand-receptor interaction 💬
1件: HRH2 💬 Famotidine 💬 Famotidine 7件:  6 , 46, 61, 86, 98, 145, 300 💬
202 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Beclomethasone dipropionate 💬 Beclomethasone dipropionate 3件: 85, 97, 98 💬
203 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Beclometasone 💬 Beclomethasone dipropionate 3件: 85, 97, 98 💬
204 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Beclomethasone dipropionate monohydrate 💬 Beclomethasone dipropionate 3件: 85, 97, 98 💬
205 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Budesonide 💬 Budesonide 9件: 66, 93, 94, 95, 96, 97, 98, 228, 299 💬
206 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Fluticasone 💬 Fluticasone 4件: 98, 228, 299, 306 💬
207 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Fluticasone propionate 💬 Fluticasone propionate 3件: 98, 228, 306 💬
208 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Hydrocortisone 💬 Hydrocortisone 11件:  6 , 41, 46, 53, 75, 78, 81, 83, 97, 98, 299 💬
209 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Mometasone 💬 Mometasone 2件: 98, 162 💬
210 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Mometasone furoate 💬 Mometasone furoate 2件: 98, 162 💬
211 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Mometasone furoate hydrate 💬 Mometasone furoate 2件: 98, 162 💬
212 Neuroactive ligand-receptor interaction 💬
3件: S1PR1, S1PR4, S1PR5 💬 Etrasimod 💬 Etrasimod 3件: 96, 97, 98 💬
213 Neuroactive ligand-receptor interaction 💬
3件: S1PR1, S1PR4, S1PR5 💬 Etrasimod arginine 💬 Etrasimod 3件: 96, 97, 98 💬
214 Neutrophil extracellular trap formation 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
215 NF-kappa B signaling pathway 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
216 Nicotine addiction 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
217 NOD-like receptor signaling pathway 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
218 Non-alcoholic fatty liver disease 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
219 Osteoclast differentiation 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
220 Oxidative phosphorylation 💬
2件: ATP4A, ATP4B 💬 Dexlansoprazole 💬 Dexlansoprazole 1件: 98 💬
221 Oxidative phosphorylation 💬
2件: ATP4A, ATP4B 💬 Dexlansoprazole sesquihydrate 💬 Dexlansoprazole 1件: 98 💬
222 Oxidative phosphorylation 💬
2件: ATP4A, ATP4B 💬 Esomeprazole magnesium 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
223 Oxidative phosphorylation 💬
2件: ATP4A, ATP4B 💬 Esomeprazole sodium 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
224 Oxidative phosphorylation 💬
2件: ATP4A, ATP4B 💬 Esomeprazole 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
225 Oxidative phosphorylation 💬
2件: ATP4A, ATP4B 💬 Esomeprazole strontium 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
226 Oxidative phosphorylation 💬
2件: ATP4A, ATP4B 💬 Esomeprazole magnesium dihydrate 💬 Esomeprazole 10件:  6 , 13, 46, 86, 98, 107, 113, 234, 298, 299 💬
227 Oxidative phosphorylation 💬
2件: ATP4A, ATP4B 💬 Omeprazole 💬 Omeprazole 16件:  6 , 13, 21, 46, 51, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
228 Oxidative phosphorylation 💬
2件: ATP4A, ATP4B 💬 Omeprazole sodium 💬 Omeprazole 16件:  6 , 13, 21, 46, 51, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
229 Oxidative phosphorylation 💬
2件: ATP4A, ATP4B 💬 Omeprazole magnesium 💬 Omeprazole 16件:  6 , 13, 21, 46, 51, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
230 Oxidative phosphorylation 💬
2件: ATP4A, ATP4B 💬 Vonoprazan 💬 Vonoprazan 3件: 63, 97, 98 💬
231 Pancreatic cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
232 Pancreatic secretion 💬
1件: CHRM3 💬 Bethanechol chloride 💬 Bethanechol 1件: 98 💬
233 Parathyroid hormone synthesis, secretion and action 💬
1件: VDR 💬 Cholecalciferol 💬 Cholecalciferol 23件:  6 , 11, 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 65, 84, 85, 96, 97, 98, 162, 228, 271, 298, 299 💬
234 Pathogenic Escherichia coli infection 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
235 Pathways in cancer 💬
1件: AGTR1 💬 Losartan potassium 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
236 Pathways in cancer 💬
1件: AGTR1 💬 Losartan 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
237 Pathways in cancer 💬
1件: IL13 💬 Cendakimab 💬 Cendakimab 1件: 98 💬
238 Pathways in cancer 💬
1件: IL4R 💬 Dupilumab 💬 Dupilumab 5件: 51, 97, 98, 160, 162 💬
239 Pathways in cancer 💬
1件: IL5 💬 Mepolizumab 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
240 Pathways in cancer 💬
1件: IL5 💬 Reslizumab 💬 Reslizumab 2件: 44, 98 💬
241 Pathways in cancer 💬
1件: IL5RA 💬 Benralizumab 💬 Benralizumab 5件: 44, 45, 98, 162, 299 💬
242 Pathways in cancer 💬
1件: KIT 💬 Barzolvolimab 💬 Barzolvolimab 1件: 98 💬
243 Pathways in cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
244 Pathways of neurodegeneration - multiple diseases 💬
3件: CHRM1, CHRM3, CHRM5 💬 Bethanechol chloride 💬 Bethanechol 1件: 98 💬
245 Pathways of neurodegeneration - multiple diseases 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
246 Pathways of neurodegeneration - multiple diseases 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
247 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
248 Pertussis 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
249 Phospholipase D signaling pathway 💬
1件: AGTR1 💬 Losartan potassium 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
250 Phospholipase D signaling pathway 💬
1件: AGTR1 💬 Losartan 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
251 Phospholipase D signaling pathway 💬
1件: FCER1A 💬 Omalizumab 💬 Omalizumab 7件: 46, 53, 65, 98, 162, 226, 299 💬
252 Phospholipase D signaling pathway 💬
1件: KIT 💬 Barzolvolimab 💬 Barzolvolimab 1件: 98 💬
253 Phospholipase D signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
254 PI3K-Akt signaling pathway 💬
2件: CHRM1, CHRM2 💬 Bethanechol chloride 💬 Bethanechol 1件: 98 💬
255 PI3K-Akt signaling pathway 💬
1件: IL4R 💬 Dupilumab 💬 Dupilumab 5件: 51, 97, 98, 160, 162 💬
256 PI3K-Akt signaling pathway 💬
1件: KIT 💬 Barzolvolimab 💬 Barzolvolimab 1件: 98 💬
257 PI3K-Akt signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
258 Prion disease 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
259 Prostate cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
260 Proteoglycans in cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
261 Proteoglycans in cancer 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
262 Rap1 signaling pathway 💬
1件: KIT 💬 Barzolvolimab 💬 Barzolvolimab 1件: 98 💬
263 Ras signaling pathway 💬
1件: KIT 💬 Barzolvolimab 💬 Barzolvolimab 1件: 98 💬
264 Regulation of actin cytoskeleton 💬
5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 Bethanechol chloride 💬 Bethanechol 1件: 98 💬
265 Renin secretion 💬
1件: AGTR1 💬 Losartan potassium 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
266 Renin secretion 💬
1件: AGTR1 💬 Losartan 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
267 Renin-angiotensin system 💬
1件: AGTR1 💬 Losartan potassium 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
268 Renin-angiotensin system 💬
1件: AGTR1 💬 Losartan 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
269 Retrograde endocannabinoid signaling 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
270 Rheumatoid arthritis 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
271 RIG-I-like receptor signaling pathway 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
272 Salivary secretion 💬
1件: CHRM3 💬 Bethanechol chloride 💬 Bethanechol 1件: 98 💬
273 Salmonella infection 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
274 Serotonergic synapse 💬
3件: GABRB, GABRB, GABRB 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
275 Serotonergic synapse 💬
5件: HTR3, HTR3, HTR3, HTR3, HTR3 💬 Ondansetron hydrochloride hydrate 💬 Ondansetron 5件:  6 , 97, 98, 107, 231 💬
276 Serotonergic synapse 💬
5件: HTR3, HTR3, HTR3, HTR3, HTR3 💬 Ondansetron 💬 Ondansetron 5件:  6 , 97, 98, 107, 231 💬
277 Serotonergic synapse 💬
1件: SLC6A4 💬 Citalopram hydrobromide 💬 Citalopram 5件:  6 , 13, 46, 98, 127 💬
278 Serotonergic synapse 💬
1件: SLC6A4 💬 Citalopram 💬 Citalopram 5件:  6 , 13, 46, 98, 127 💬
279 Shigellosis 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
280 Shigellosis 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
281 Sphingolipid signaling pathway 💬
1件: FCER1A 💬 Omalizumab 💬 Omalizumab 7件: 46, 53, 65, 98, 162, 226, 299 💬
282 Sphingolipid signaling pathway 💬
3件: S1PR1, S1PR4, S1PR5 💬 Etrasimod 💬 Etrasimod 3件: 96, 97, 98 💬
283 Sphingolipid signaling pathway 💬
3件: S1PR1, S1PR4, S1PR5 💬 Etrasimod arginine 💬 Etrasimod 3件: 96, 97, 98 💬
284 Sphingolipid signaling pathway 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
285 Spinocerebellar ataxia 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
286 Synaptic vesicle cycle 💬
1件: SLC6A4 💬 Citalopram hydrobromide 💬 Citalopram 5件:  6 , 13, 46, 98, 127 💬
287 Synaptic vesicle cycle 💬
1件: SLC6A4 💬 Citalopram 💬 Citalopram 5件:  6 , 13, 46, 98, 127 💬
288 Systemic lupus erythematosus 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
289 T cell receptor signaling pathway 💬
1件: IL5 💬 Mepolizumab 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
290 T cell receptor signaling pathway 💬
1件: IL5 💬 Reslizumab 💬 Reslizumab 2件: 44, 98 💬
291 T cell receptor signaling pathway 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
292 Taste transduction 💬
1件: CHRM3 💬 Bethanechol chloride 💬 Bethanechol 1件: 98 💬
293 Taste transduction 💬
6件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
294 Taste transduction 💬
5件: HTR3, HTR3, HTR3, HTR3, HTR3 💬 Ondansetron hydrochloride hydrate 💬 Ondansetron 5件:  6 , 97, 98, 107, 231 💬
295 Taste transduction 💬
5件: HTR3, HTR3, HTR3, HTR3, HTR3 💬 Ondansetron 💬 Ondansetron 5件:  6 , 97, 98, 107, 231 💬
296 TGF-beta signaling pathway 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
297 Th1 and Th2 cell differentiation 💬
1件: IL13 💬 Cendakimab 💬 Cendakimab 1件: 98 💬
298 Th1 and Th2 cell differentiation 💬
1件: IL4R 💬 Dupilumab 💬 Dupilumab 5件: 51, 97, 98, 160, 162 💬
299 Th1 and Th2 cell differentiation 💬
1件: IL5 💬 Mepolizumab 💬 Mepolizumab 4件: 44, 45, 98, 162 💬
300 Th1 and Th2 cell differentiation 💬
1件: IL5 💬 Reslizumab 💬 Reslizumab 2件: 44, 98 💬
301 Th17 cell differentiation 💬
1件: IL4R 💬 Dupilumab 💬 Dupilumab 5件: 51, 97, 98, 160, 162 💬
302 Th17 cell differentiation 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
303 Thermogenesis 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
304 Thyroid hormone signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
305 TNF signaling pathway 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
306 Toll-like receptor signaling pathway 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
307 Toxoplasmosis 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
308 Tuberculosis 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
309 Tuberculosis 💬
1件: VDR 💬 Cholecalciferol 💬 Cholecalciferol 23件:  6 , 11, 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 65, 84, 85, 96, 97, 98, 162, 228, 271, 298, 299 💬
310 Type I diabetes mellitus 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
311 Type II diabetes mellitus 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
312 Type II diabetes mellitus 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
313 Vascular smooth muscle contraction 💬
1件: AGTR1 💬 Losartan potassium 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
314 Vascular smooth muscle contraction 💬
1件: AGTR1 💬 Losartan 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
315 Viral protein interaction with cytokine and cytokine receptor 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬
316 Yersinia infection 💬
1件: TNF 💬 Infliximab 💬 Infliximab 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 164, 269, 270, 271 💬